scispace - formally typeset
R

Romana T. Netea-Maier

Researcher at Radboud University Nijmegen

Publications -  147
Citations -  10898

Romana T. Netea-Maier is an academic researcher from Radboud University Nijmegen. The author has contributed to research in topics: Medicine & Thyroid cancer. The author has an hindex of 35, co-authored 127 publications receiving 8975 citations. Previous affiliations of Romana T. Netea-Maier include Radboud University Nijmegen Medical Centre.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Metabolic Induction of Trained Immunity through the Mevalonate Pathway

Siroon Bekkering, +17 more
- 11 Jan 2018 - 
TL;DR: It is reported that metabolic signals can induce trained immunity and the role of mevalonate in trained immunity contributes to the understanding of the pathophysiology of HIDS and identifies novel therapeutic targets for clinical conditions with excessive activation of trained immunity.
Journal ArticleDOI

Host and Environmental Factors Influencing Individual Human Cytokine Responses

Rob ter Horst, +30 more
- 03 Nov 2016 - 
TL;DR: A strong impact of non-genetic host factors (e.g., age and gender) on cytokine production and circulating mediators is shown and annual seasonality is found to be an important environmental factor influencing cytokineproduction.
Journal ArticleDOI

Modulation of inflammation by autophagy: Consequences for human disease

Romana T. Netea-Maier, +4 more
- 26 Jan 2016 - 
TL;DR: The crosstalk between autophagy and inflammation is focused on as an emerging field with major implications for understanding the host defense on the one hand, and for the pathogenesis and treatment of immune-mediated diseases on the other hand.
Journal ArticleDOI

Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease

Richard A Feelders, +12 more
- 13 May 2010 - 
TL;DR: Pasireotide is a new somatostatin analogue that binds with high affinity to som atostatin-receptor subtypes 1, 2, and 3, and it especially has high-affinity binding to somatstatin- receptor subtype 5.